DVA vs LH
DaVita Inc. and Labcorp Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DVA | LH |
|---|---|---|
| Revenue | $13.6B | $14.0B |
| Net income | $746.8M | $876.5M |
| Gross margin | · | 28.8% |
| Net margin | 7.9% | 6.3% |
| Return on equity | · | 10.5% |
| Diluted EPS | $9.84 | $10.46 |
| Dividend / share | · | $2.88 |
| Payout ratio | 0.0% | 27.5% |
| Free cash flow | $1.3B | $1.2B |
| Equity | $-651.1M | $8.6B |
| Net debt / equity | · | 0.59× |
| Current ratio | 1.29× | 1.42× |
| Revenue CAGR 5y | 3.4% | −0.0% |
| Profit CAGR 5y | −0.7% | −10.8% |
DVA and LH book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (7.9% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | DVA | LH |
|---|---|---|
| FY2025 | $13.6B | $14.0B |
| FY2024 | $12.8B | $13.0B |
| FY2023 | $12.1B | $12.2B |
| FY2022 | $11.6B | $11.9B |
| FY2021 | $11.6B | $13.1B |
| FY2020 | $11.6B | $14.0B |
| FY2019 | $11.4B | $11.6B |
| FY2018 | $11.4B | $11.3B |
| FY2017 | $10.9B | $10.3B |
| FY2016 | $10.7B | $9.6B |
Bottom line
| Fiscal year | DVA | LH |
|---|---|---|
| FY2025 | $746.8M | $876.5M |
| FY2024 | $936.3M | $746.0M |
| FY2023 | $691.5M | $418.0M |
| FY2022 | $560.4M | $1.3B |
| FY2021 | $978.5M | $2.4B |
| FY2020 | $773.6M | $1.6B |
| FY2019 | $811.0M | $823.8M |
| FY2018 | $159.4M | $883.7M |
| FY2017 | $663.6M | $1.2B |
| FY2016 | $879.9M | $711.8M |
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$308,631,000 | LH |
| FY2024 | −$193,350,000 | LH |
| FY2023 | −$21,453,000 | LH |
| FY2022 | −$254,006,000 | LH |
| FY2021 | −$1,517,303,000 | LH |
| FY2020 | −$2,427,896,000 | LH |
| FY2019 | −$166,321,000 | LH |
| FY2018 | +$71,451,000 | DVA |
| FY2017 | +$568,634,000 | DVA |
| FY2016 | +$1,154,567,000 | DVA |
| FY2015 | +$1,302,145,000 | DVA |
| FY2014 | +$6,783,506,000 | DVA |
| FY2013 | +$5,955,750,000 | DVA |
| FY2012 | +$2,514,880,000 | DVA |
| FY2011 | +$1,189,506,000 | DVA |
| FY2010 | +$1,215,710,000 | DVA |
The higher-revenue side has changed between DVA and LH over this period. The gap has narrowed since the earliest year compared.
16 of 19 comparable fiscal years — a year missing data on either side is not counted.
16 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +1.6 pp | DVA |
| FY2024 | +4.0 pp | DVA |
| FY2023 | +4.4 pp | DVA |
| FY2022 | −4.1 pp | LH |
| FY2021 | −7.7 pp | LH |
| FY2020 | −2.5 pp | LH |
| FY2019 | +1.8 pp | DVA |
| FY2018 | −4.9 pp | LH |
| FY2017 | −4.3 pp | LH |
| FY2016 | +2.2 pp | DVA |
| FY2015 | −0.8 pp | LH |
| FY2014 | −1.8 pp | LH |
| FY2013 | −3.5 pp | LH |
| FY2012 | −2.5 pp | LH |
| FY2011 | −1.1 pp | LH |
| FY2010 | −3.6 pp | LH |
The higher net margin has changed hands between DVA and LH over this period.
16 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
LH's net margin has been more volatile than DVA's over the 16 comparable fiscal years — 3.4 percentage points of standard deviation against 1.9.
16 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DVA and LH over these 16 fiscal years — DVA led in 5 and LH in 11.
16 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
DVA's return on equity has been more volatile than LH's over the 17 comparable fiscal years — 39.5 percentage points of standard deviation against 6.4.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DVA and LH over these 17 fiscal years — DVA led in 10 and LH in 7.
17 of 19 comparable fiscal years — a year missing data on either side is not counted.